Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 2/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | HTR2A | P28223 | 2/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.34 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.34 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.34 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30705746 | 0.89 | TRPA1 (0.59) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| Benzyl Bromide SCHEMBL1043932 | 0.87 | TSHR (0.70) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| SCHEMBL10426400 | 0.83 | ALDH1A1 (0.52) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| SCHEMBL739399 | 0.82 | TDP1 (0.67) | ALDH1A1TDP1CYP3A4ESR1ESR2 | |
| SCHEMBL2462689 | 0.82 | TDP1 (0.67) | ALDH1A1TDP1CYP3A4ESR1ESR2 | |
| SCHEMBL15201372 | 0.82 | TRPA1 (0.50) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| SCHEMBL2646943 | 0.82 | TSHR (0.50) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| SCHEMBL1503288 | 0.82 | ALDH1A1 (0.50) | ALDH1A1TSHRTRPA1TDP1CYP3A4 | |
| SCHEMBL7536 | 0.79 | — | — | |
| SCHEMBL4410065 | 0.79 | TRPA1 (0.46) | ALDH1A1TSHRTRPA1TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4658656-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | Beone Medicines I GmbH (CH) | 2025-12-10 | — | — | EP | disclosed |
| WO-2025200154-A1 | TWO-PART EPOXY COMPOSITION COMPRISING THIOL CURATIVE, AND CATALYST | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-10-02 | — | — | WO | disclosed |
| CN-119907795-A | Antibacterial compounds | 布莱克史密斯医药公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-119451943-A | Novel substituted 4-amino-4-oxo-but-2-enyl derivatives, process for their preparation and their therapeutic use | 赛诺菲 | 2025-02-14 | — | — | CN | disclosed |
| CN-119013251-A | Substituted 6, 7-dihydro-5H-benzo [7] rotaene derivatives, process for their preparation and their therapeutic use | 赛诺菲 | 2024-11-22 | — | — | CN | disclosed |
| WO-2024160276-A1 | CONDENSED HETEROCYCLIC COMPOUNDS AS INHIBITOR OF DIACYLGLYCEROL KINASES | BEIGENE, LTD. (KY) | 2024-08-08 | — | — | WO | disclosed |
| CN-117580592-A | Compounds for targeting bruton's tyrosine kinase degradation | 渤健马萨诸塞州股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-116615414-A | Substituted 6, 7-dihydro-5H-benzo [7] rotaline compounds and derivatives thereof, method for the production and therapeutic use thereof | 赛诺菲 | 2023-08-18 | — | — | CN | disclosed |
| CN-114957128-A | Diaryl imidazolium salt and antibacterial application thereof | 四川大学 | 2022-08-30 | — | — | CN | disclosed |
| CN-113166618-B | Adhesive composition and surface protective film | DIC株式会社 | 2022-08-23 | — | — | CN | disclosed |
| US-7638663-B2 | large energy gap; use in electronic appliance with low power consumption; e.g. 3,3'-di(phenanthrene-9-yl)stilbene | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-12-29 | — | — | US | disclosed |
| EP-2074093-A2 | MATRIX METALLOPROTEINASE INHIBITORS | Ranbaxy Laboratories Limited (IN) | 2009-07-01 | — | — | EP | disclosed |
| US-20080088229-A1 | Stilbene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-17 | — | — | US | disclosed |
| US-20080091030-A1 | Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2008-04-17 | — | — | US | disclosed |
| WO-2008023336-A2 | MATRIX METALLOPROTEINASE INHIBITORS | RANBAXY LABORATORIES LIMITED (IN) | 2008-02-28 | — | — | WO | disclosed |
| US-20070100180-A1 | Stilbene derivative, light emitting element material, light emitting element, light emitting device and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2007-05-03 | — | — | US | disclosed |
| US-6747023-B1 | INHIBITORS FOR ACTIVATED COAGULATION FACTOR X, COAGULATION SUPPRESSORS | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-06-08 | — | — | US | disclosed |
| US-20040082611-A1 | Anticoagulants; brain disorders; respiratory system disorders; side effect reduction | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2004-04-29 | — | — | US | disclosed |
| EP-1104754-A1 | NOVEL SULFONYL DERIVATIVES | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2001-06-06 | — | — | EP | disclosed |
| JP-2001010992-A | BLUE COLOR LIGHT-EMITTING COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT USING THE SAME AND DISPLAY ELEMENT ADOPTING THE SAME AS LUMINESCENT MATERIAL | SAMSUNG SDI CO LTD | 2001-01-16 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080091030-A1 | Stilbene Derivatives, Light-Emitting Element, Display Device, and Electronic Device | NR2E3, NR0B2, NR0B1 | ALDH1A1 4/4885TSHR 3440/4885TRPA1 608/4885 |
| US-20040082611-A1 | Anticoagulants; brain disorders; respiratory system disorders; side effect reduction | F2, CYC1, SULT2A1 | ALDH1A1 1316/4885TSHR 238/4885TRPA1 2376/4885 |
| US-20080088229-A1 | Stilbene Derivative, Light-Emitting Element, Light-Emitting Device, and Electronic Device | HSF1, HSPA1B, HSPB1 | ALDH1A1 21/4885TSHR 3967/4885TRPA1 49/4885 |
| US-20070100180-A1 | Stilbene derivative, light emitting element material, light emitting element, light emitting device and electronic appliance | TLL1, MT-ATP8, TLL2 | ALDH1A1 280/4885TSHR 3849/4885TRPA1 634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.